successful treatment of intracranial hemorrhage with recombinant activated factor vii in a patient with newly diagnosed acute myeloid leukemia: a case report and review of the literature

successful treatment of intracranial hemorrhage with recombinant activated factor vii in a patient with newly diagnosed acute myeloid leukemia: a case report and review of the literature

;Naveen ePemmaraju;Koji eSasaki;Daniel eJohnson;Naval eDaver;Vahid eAfshar-Kharghan;Merry eChen;Sairah eAhmed;Rivka R Colen;Michael eKwon;Yang eHuh;Gautam eBorthakur
international journal of heat and technology 2015 Vol. 5 pp. -
209
epemmaraju2015frontierssuccessful

Abstract

Intracranial hemorrhage (ICH) is a common complication in acute myeloid leukemia (AML) patients with an incidence rate of 6.3% [1]. Bleeding disorders related to disseminated intravascular coagulation (DIC) are common complications in AML cases [2]. Recombinant activated Factor VII (rFVIIa [NovoSeven®]) is approved for the treatment of bleeding complications with FVIII or FIX inhibitors in patients with congenital FVII deficiency. Use of rFVIIa for the treatment of acute hemorrhage in patients without hemophilia has been successful [3,4]. Herein, we describe the successful use of rFVIIa in a patient with acute ICH in the setting of newly diagnosed AML.

Citation

ID: 198150
Ref Key: epemmaraju2015frontierssuccessful
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
198150
Unique Identifier:
10.3389/fonc.2015.00029
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet